APA (7th ed.) Citation

M, D., A, B., A, P., J, A., W, A., M, S., . . . SJ, D. (2015). Anti-EFNA4 Calicheamicin Conjugates Effectively Target Triple-Negative Breast and Ovarian Tumor-Initiating Cells to Result in Sustained Tumor Regressions. Clinical cancer research : an official journal of the American Association for Cancer Research, 21(18), 4165. https://doi.org/10.1158/1078-0432.CCR-15-0695

Chicago Style (17th ed.) Citation

M, Damelin, et al. "Anti-EFNA4 Calicheamicin Conjugates Effectively Target Triple-Negative Breast and Ovarian Tumor-Initiating Cells to Result in Sustained Tumor Regressions." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 21, no. 18 (2015): 4165. https://doi.org/10.1158/1078-0432.CCR-15-0695.

MLA (9th ed.) Citation

M, Damelin, et al. "Anti-EFNA4 Calicheamicin Conjugates Effectively Target Triple-Negative Breast and Ovarian Tumor-Initiating Cells to Result in Sustained Tumor Regressions." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 21, no. 18, 2015, p. 4165, https://doi.org/10.1158/1078-0432.CCR-15-0695.